The FDA approved GI Scientific's ScopeSeal Duodenoscope Protective Device, a device that protects the distal end of a duodenoscope during endoscopic retrograde cholangiopancreatography procedures.
GI & Endoscopy
Three leaders in gastroenterology to know this week:
AbbVie earned the European Commission's approval to acquire Allergan, with one condition.
Adam Bell, DO, joined St. Joseph Regional Medical Center in Lewiston, Idaho,, the Daily Fly reports.
HSHS Medical Group's specialty practice in Effingham, Ill., joined the Effingham Chamber of Commerce, Effingham Daily News reports.
Advertisement
A rise in upper gastroenterology endoscopy to diagnose and treat esophageal diseases will propel high demand for GI procedures in the next decade, according to Sg2's 2019 Impact of Change forecast.
With patient awareness of colorectal cancer on the rise and the resulting push for younger patients to be screened for the disease, pay and demand for gastroenterologists is increasing.
The following gastroenterologists have been featured in the news recently:
St. Joseph Hospital in Bethpage, N.Y. and Mercy Medical Center in Rockville Centre, N.Y. named Lynn O'Connor, MD, as the new chief of colon and rectal surgery. Both hospitals are part of the Catholic Health Services health system.
Here are six updates from gastroenterology companies and practices from the past week: